Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nano Hearing Aids is a private U.S. hearing health company focused on direct-to-consumer, over-the-counter hearing devices for adults with perceived mild to moderate hearing loss. Founded in 2017, the company sells affordable OTC-compliant hearing aids online and has expanded its portfolio to include rechargeable, in-the-ear, behind-the-ear, receiver-in-canal, Bluetooth-enabled, and app-controlled products. Recent named products highlighted by the company include Audacity, First Ear Pro CIC, and First Ear Plus BTE. Nano positions itself around accessibility, affordability, and consumer convenience, with products sold directly through its website and other e-commerce channels. The business is healthcare-related, but it is a commercial medical device and hearing wellness company rather than a biotech or therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nano Hearing Aids.